Your browser doesn't support javascript.
loading
Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study.
Mehanna, Hisham; Bryant, Tyler S; Babrah, Jaspreet; Louie, Karly; Bryant, Jennifer L; Spruce, Rachel J; Batis, Nikolaos; Olaleye, Oladejo; Jones, June; Struijk, Linda; Molijn, Anco; Vorsters, Alex; Rosillon, Dominique; Taylor, Sylvia; D'Souza, Gypsyamber.
Afiliação
  • Mehanna H; Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom.
  • Bryant TS; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Babrah J; Cancer Research UK Clinical Trials Unit, University of Birmingham, United Kingdom.
  • Louie K; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, United Kingdom.
  • Bryant JL; Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom.
  • Spruce RJ; Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom.
  • Batis N; Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom.
  • Olaleye O; Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom.
  • Jones J; Institute of Head and Neck Studies and Education, College of Medical and Dental Sciences, University of Birmingham, United Kingdom.
  • Struijk L; DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
  • Molijn A; DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
  • Vorsters A; Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, GlaxoSmithKline, Wavre, Belgium.
  • Rosillon D; Clinical and Epidemiology Research Development, GlaxoSmithKline, Wavre, Belgium.
  • Taylor S; Clinical and Epidemiology Research Development, GlaxoSmithKline, Wavre, Belgium.
  • D'Souza G; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Clin Infect Dis ; 69(8): 1296-1302, 2019 09 27.
Article em En | MEDLINE | ID: mdl-30590469
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / Programas de Imunização / Infecções por Papillomavirus / Imunidade Coletiva / Papillomavirus Humano 16 / Vacinas contra Papillomavirus Tipo de estudo: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / Programas de Imunização / Infecções por Papillomavirus / Imunidade Coletiva / Papillomavirus Humano 16 / Vacinas contra Papillomavirus Tipo de estudo: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido